AFS 2025 Conference Fee

Conference fee of $1,195 includes tuition, syllabus materials, lunch and coffee breaks. All registrations will be confirmed via email.  If you do not receive a confirmation, please call 603-897-5510.

AFS 2025 Syllabus

Target Audience

This activity has been designed to meet the educational needs of cardiologists, internists, fellows, physician assistants, registered nurses, nurse practitioners, and other medical professionals involved in the care of patients with atrial fibrillation.

This three-day symposium is designed to meet the following objectives:

1. Provide a current review of new information on
   the clinical science and pathophysiology of atrial fibrillation and atrial fibrillation-related
   stroke

2. Provide a detailed presentation of the most
   recent developments in the diagnosis and treatment of atrial fibrillation

3. Discuss the prevention of AF-related stroke and
   other sequelae, with an emphasis on current and evolving pharmacological and nonpharmacological therapies and enabling new technologies in the field of cardiac electrophysiology

4. Exchange thoughts and techniques with the
   treatment team to improve the outcome of patient care and treatment

5. Provide appropriate care and counsel for
   patients and their families through the education of healthcare professionals

Disclosure of All Financial Relationships

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.